North America Addictions Therapeutics Market Developments and Forecast by 2027

The North America Addictions Therapeutics market is expected to reach US$ 6,102.31 million by 2027 from US$ 3,715.23 million in 2019. The market is estimated to grow with a CAGR of 6.5% from 2020 to 2027.

The growth of the market is attributed to rising approval of new drugs and launch of digital therapeutics to treat addiction, conduction of various awareness campaigns and government efforts to counteract drug abuse and promote medication. However, high cost associated with drug development is hindering the growth of the addiction therapeutics market.

Drug addiction, also referred to as substance disorder, is a type of disease that hampers an individual’s brain, behavior, and metabolic processes leading to an inability to control. Non-medical use and abuse of prescription drugs are becoming severe issues worldwide. Addiction to abusive substances is responsible for the death of millions of people across the world. According to the National Institute on Drug Abuse (NIDA) estimates, ~21 million people across the world had at least one addiction in 2019, out of which only 10% received treatment for the same. The Addiction Center reports state that the number of people undertaking treatments for addictions has increased in recent years. Thus, the rising awareness among people about drug addiction treatment is likely to support the growth of the North America addiction therapeutics market in the coming years. Similarly, awareness campaigns and government efforts to counteract drug abuse and promote medication for all sorts of addiction treatments would fuel the market growth during the forecast period.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

North America Addictions Therapeutics Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

The COVID-19 pandemic is hindering the North America addictions therapeutics market. Due to the outbreak of disease, healthcare industries have been affected severely, considering the economic conditions in the current situation. Moreover, the traditional difficulties regarding treatment access and adherence for the population suffering from addictions will worsen during the pandemic, therefore aggravating their condition.

North America Addictions Therapeutics Market Report Scope

North America Addictions Therapeutics Market Players Density: Understanding Its Impact on Business Dynamics

The North America Addictions Therapeutics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

North America Addictions Therapeutics Market Segmentation

By Treatment Type

• Opioid Addiction Treatment
• Alcohol Addiction Treatment
• Nicotine Addiction Treatment
• Other Substance Addiction Treatment

By Drug Type

• Buprenorphine
• Naltrexone
• Bupropion
• Disulfiram
• Nicotine Replacement Products
• Varenicline
• Others

By Treatment Center

• Inpatient Treatment Center
• Residential Treatment Center
• Outpatient Treatment Center

By Distribution Channel

• Hospital Pharmacies
• Medical stores
• Others

By Country

• United States
• Canada
• Mexico

Company Profiles

• Indivior PLC
• Pfizer Inc
• GlaxoSmithKline plc
• Bausch Health Companies Inc
• Cipla Inc.
• Orexo AB
• Purdue Pharma L.P
• Alvogen
• Camurus AB
• Hikma Pharmaceuticals PLC